nav_top

Username:
Password:

Remember Me
Forgot Password

Benefits of Membership
Search By Keyword Or Search By

Getting to Goal for ADHD: Managed Care Strategies for the Diagnosis and Treatment of Childhood and Adolescent ADHD

Release Date: February 23, 2009
Expiration Date: February 28, 2011

THIS ACTIVITY IS NO LONGER VALID FOR CME/CE CREDIT.

TARGET AUDIENCE
This activity has been designed to meet the educational needs of physicians, managed care pharmacists, pharmacy directors, medical directors, quality directors, policy executives, and other key managed care administrators.

STATEMENT OF NEED
Attention-deficit/hyperactivity disorder (ADHD) is a neurobehavioral syndrome characterized by inattentiveness or distractibility, with or without impulsivity, and hyperactivity. It is associated with serious and persistent difficulties in childhood, adolescence, and it often extends indefinitely into adult life. The disorder typically becomes apparent and is most commonly diagnosed in childhood and/or adolescence, with approximately half of all patients being diagnosed before 13 years of age. In fact, ADHD is considered to be the most common neurobehavioral disorder in children, affecting up to an estimated 12% of school-aged children and persisting to adolescence in up to 70% of cases. Although this condition remains under-recognized in general, more than 4 million children and adolescents aged 4 to 17 years have been diagnosed with ADHD. Treating patients with ADHD within a managed care organization (MCO) involves unique challenges because primary care physicians (PCPs), not psychiatrists, must recognize the disorder and either provide care themselves or make appropriate referrals and coordinate care.

EDUCATIONAL OBJECTIVES
At the conclusion of this continuing education activity, participants should be able to:

  • Identify ADHD as a treatable neurobiological disease within a childhood and adolescent patient population in managed care
  • Explain the barriers to managed care's appropriate treatment of ADHD
  • Outline the safety and efficacy of current treatment in childhood and adolescent patients

FACULTY INFORMATION
Julie Dopheide, PharmD, BCPP
(Click on faculty name to view full biography)
Associate Professor of Clinical Pharmacy, Psychiatry and the Behavioral Sciences
University of Southern California
Schools of Pharmacy and Medicine
Los Angeles, CA

Peter S. Jensen, MD
(Click on faculty name to view full biography)
President & CEO
The REACH Institute
REsource for Advancing Children's Health
New York, NY

Neil B. Minkoff, MD
(Click on faculty name to view full biography)
Medical Director
Network Medical Management and Pharmacy
Harvard Pilgrim Health Care
Wellesley, MA

COMMERCIAL SUPPORT
This activity is supported by an educational grant from Ortho-McNeil Janssen Scientific Affairs, LLC.

DISCLOSURE DECLARATION
Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Faculty or Presenter Reported Financial Relationship
Julie Dopheide, PharmD, BCPP Consulting Fee: Ortho-McNeil Janssen Scientific Affairs, LLC, Shire
Peter S. Jensen, MD Consulting Fee: Otsuka America Pharmaceutical, Inc.
Fees for Non-CME: Ortho-McNeil Janssen Scientific Affairs, LLC, Otsuka America Pharmaceutical, Inc., Shire
Neil B. Minkoff, MD No financial interest/relationships relating to the topic of this activity

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Planner or Manager Reported Financial Relationship
Steve Casebeer, MBA No financial interest/relationships with financial interests relating to the topic of this activity
Trace Hutchison, PharmD (PIM) No financial interest/relationships with financial interests relating to the topic of this activity
Jan Hixon, RN, BSN, MA (PIM) No financial interest/relationships with financial interests relating to the topic of this activity
Linda Graham, RN, BSN, BA (PIM) No financial interest/relationships with financial interests relating to the topic of this activity
Julia Kirkwood, RN, BSN (PIM) No financial interest/relationships with financial interests relating to the topic of this activity
Jan Schultz, RN, MSN (PIM) No financial interest/relationships with financial interests relating to the topic of this activity

Other Disclosures
This activity is jointly sponsored by Postgraduate Institute for Medicine and Impact Education, LLC.

For information about the accreditation of this activity, please contact Postgraduate Institute for Medicine at (303) 799-1930 or information@pimed.com.

MEDIA
Interactive Online Monograph

DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Postgraduate Institute for Medicine (PIM), Impact Education, LLC, and Ortho-McNeil Janssen Scientific Affairs, LLC do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, Impact Education, LLC, and Ortho-McNeil Janssen Scientific Affairs, LLC. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

SOFTWARE REQUIREMENTS
PC
Microsoft Windows 2000 SE or above.
Flash Player Plugin (v8 or greater)
Internet Explorer (v5.5 or greater), or Firefox
Adobe Acrobat Reader*

MAC
MAC OS 10.2.8
Flash Player Plugin (v8 or greater)
Safari
Adobe Acrobat Reader*
Internet Explorer is not supported on the Macintosh.

* Required to view printable (PDF) version of the lesson.

Continue